Research lines

Our main research lines are the following:

• Clinical trials for validation of new drugs, demonstration of the predictive value of biomarkers, or determination of the recommended dose of treatment.
• Study and validation of new biomarkers from liquid biopsies, from ctDNA and microRNAs.
• Molecular and functional analysis of tumor heterogeneity.
• Use of organoids as functional models of cancer for the study of resistance and alternative treatments.